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Abstract
Increasing numbers of patients are surviving the intensive care unit.
Concordant with our shifting focus to minimizing intensive care
unit-acquired morbidity, in the present issue of Critical Care Moyen,
Camire, and Stelfox describe the importance of quality pharmaco-
therapy. They describe challenges and potential solutions to this
source of iatrogenic injury in our vulnerable patients. Their article
reminds us not to understate the importance of medication error, to
avoid overstating the benefits of incompletely proven methods to
prevent medication error, and to distinguish harmful medication
errors from other types of medication error.
Medication error is the most commonly observed threat to
patient safety in the intensive care unit (ICU). In the present
issue of Critical Care, Moyen, Camire, and Stelfox describe the
importance of quality pharmacotherapy [1]. Their narrative
review provides insight into medication errors in this complex,
imperfect, multistakeholder process. They discuss vulnerability,
error definition and measurement, and methods to improve the
process and outcomes of pharmacotherapy in the ICU.
The ICU represents the meeting of the high-risk patient,
polypharmacy, physiologic complexity, and an interventional
environment that provides many opportunities for error [2].
Medication error is common [3-7]. Rothchild’s direct obser-
vational, single-centre study in an adult ICU found a serious
medication error occurred once every 8 patient-days. A
harmful medication error occurred every 78 patient-days, a
life-threatening medication error occurred every 300 patient-
days, and a fatal medication error occurred once every 750
patient-days (95% confidence interval, 207 to 7,450) [4]. In a
20-bed ICU this conservatively translates to one preventable
death due to a medication error every 6 to 8 weeks.
While sobering, these data remind us that all medication
errors are not equal. Definitions are important. These defini-
tions underscore our thinking and influence how measures
are used. Moyen and colleagues define a medication error as
‘any error in the medication process, whether there are
adverse consequences or not’ [8]. This definition includes
both errors of commission and errors of omission. Errors
involving omission of or delayed initiation of therapy may be
difficult to detect but are clinically important. This definition
includes near-miss errors and other errors that do not reach
patients. This is consistent with a process-of-care approach
to medication errors. An alternate, patient-centred philosophy
defines a medication error as ‘a failure in the medication
process that results in a patient failing to receive the
appropriate drug or drug dose’ [9]. This definition excludes a
near-miss error, and reflects our understanding of medication
safety systems: drugs that are not administered cannot cause
patient harm, and detecting and intercepting an error signals
a functional safety system. The confusing heterogeneity
introduced by use of these two valid definitions emphasizes
the need for clarity when discussing medication errors, and
the benefits of a standard, accepted nomenclature.
Clinical surveillance, like other forms of medication error
research, can be used to improve future care. The benefits to
the patient affected and to the providers involved in the error
are less clear [10,11]. Underreporting with voluntary methods
is routine [6]. Our culture of silence may be understandable
in environments where the one ubiquitous defence is frontline
vigilance. Underreporting is unlikely to change while profes-
sional accountability is mediated through the administrators
contributing to the implicated system-level errors.
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Voluntary reporting is at best a qualitative tool to identify
problems in a given system, and is suited to the inclusion of
near-miss events as suggested by Moyen and colleagues
[8]. The vigour of surveillance data collection should balance
the workload, the merits of the collected data, and system-
responsiveness to emerging signals [12]. Quantification of
the effectiveness of error-reducing interventions requires
more robust methods [6]. To date, only pharmacists attend-
ing multidisciplinary ICU ward rounds have been shown to
reduce harmful medication errors [13].
Medication safety begins well before the ICU. Prelicensing
evaluation, drug regulation practices, and drug manufacturers
provide incomplete safety, dosing, and effectiveness data,
that should be complimented by relevant clinical trials and
postmarketing surveillance [14]. Drug preparation before ICU
admission and within the ICU produces errors in up to 65%
of prepared infusions [15]. Fatigue, practice, and the stock
solutions produced by drug manufacturers are all contri-
butors [16]. A preparation-associated error is more frequent
than other types of medication error. The cascading effects of
licensing an unsafe drug, making a diagnostic error leading to
multiple erroneous therapies, or making a prescription error
that is repeatedly administered, however, may be far greater
than a preparation-associated error and might underscore the
need for a standard, clinically relevant metric for assessing
medication safety across these dimensions.
Reducing error is different to reducing harm. Moyen and
colleagues [1] describe computerized physician order entry,
bar-coding, smart infusion pumps, and infusion concentration
standardization as methods to reduce medication error. As
pointed out by Moyen and colleagues, none of these activities
have been shown to reduce harmful medication errors [1]. In
fact, new harmful errors may be uncovered and worse
outcomes have been reported with computerized physician
order entry in the ICU [17]. Improvement should mean fewer
harmful errors or less risk-adjusted morbidity or mortality.
Whichever metric is used, demonstration of improved patient
outcomes should be a minimum requirement before
implementation of any expensive system-level intervention.
Moyen and colleagues [1] remind us that pharmacotherapy in
the ICU is a large-calibre weapon. Patients may be harmed by
optimal pharmacotherapy. Attribution of harm is difficult;
however, large epidemiologic studies suggest that up to one-
half of adverse drug events in hospitalized patients are
preventable, and 10% of medication errors in ICU patients
result in harm [4]. This issue should not be understated.
Quality pharmacotherapy is a core component of high-calibre
ICU care. Thanks go to Moyen and colleagues for their
insightful synthesis and for promoting ongoing discussion of
this multifaceted, challenging and fundamental aspect of the
practice of critical care medicine.
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